𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks

✍ Scribed by Huiling Yang; Christopher E. Westland; William E. Delaney IV1; Elizabeth J. Heathcote; Victoria Ho; John Fry; Carol Brosgart; Craig S. Gibbs; Michael D. Miller; Shelly Xiong

Book ID
111721928
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
233 KB
Volume
36
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Increased risk of adefovir resistance in
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy
✍ Yoon-Seon Lee; Dong Jin Suh; Young-Suk Lim; Suk Won Jung; Kang Mo Kim; Han Chu L πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 239 KB

Although adefovir dipivoxil (ADV) has a unique profile of delayed and infrequent resistance in treatment-naΓ―ve chronic hepatitis B patients, the association of ADV resistance with previous lamivudine (LAM) resistance is not well understood. We compared the emergence of the ADV-resistant mutations rt